Request opinion of other members on Trius.Main target short term for this company is Staph aureus market, specifically MRSA. Only competing drug is linezolid, a Pfizer product.Linezolid market roughly 1.5 billion yearly. Trius tint but seems on track.Interested on hearing from others on possible negatives (or positives)
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Ma